APMA has the resources you need to help you through every step of your career. With detailed information about MIPS and recent coding trends along with compliance guidelines and practice marketing materials, APMA has you covered whether you are just getting started in practice, preparing for retirement, or anywhere in between.
Today's podiatrist has the necessary education and training to treat all conditions of the foot and ankle and plays a key role in keeping America healthy and mobile while helping combat diabetes and other chronic diseases.
Your feet are excellent barometers for your overall health. Healthy feet keep you moving and active. They are quite literally your foundation. In this section, learn more about APMA Seal-approved and accepted products, proper foot care, common foot and ankle conditions, and how your podiatrist can help keep you and your feet healthy.
APMA is the only organization lobbying for podiatrists and their patients on Capitol Hill. As the voice of podiatric medicine to your legislators and regulators, APMA is active on a variety of critical issues affecting podiatry and the entire health-care system.
Last Friday, APMA submitted comments to CMS in response to its solicitation for recommendations related to the MIPS 2025 Performance Year Podiatry Measure Specialty Set. APMA recommended removing Measure #219: Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairment from the Podiatry Specialty Measure Set for 2025.
APMA requested this measure’s removal due to the fact that very few physicians typically perform the actions described in this measure. This is underlined by the data—in 2021, more than 1,800 physical therapists reported Measure #219, compared to just three podiatrists in the same year. APMA is further concerned that by keeping the measure in the specialty measure set, DPMs may use it incorrectly, not fully understanding the requirements or the tool used, resulting in skewed data and results, potential misuse affecting patient care, as well as possibly poor scoring outcomes for those DPMs.
To read this letter in full, as well as all other past comment letters, visit www.apma.org/commentletters. Contact MIPS@apma.org with any questions or concerns.
11400 Rockville Pike, Suite 220
Rockville, MD 20852
301-581-9200
Contact Us
Copyright © 2024 American Podiatric Medical Association